Literature DB >> 31130493

Classification of Helicobacter pylori Virulence Factors: Is CagA a Toxin or Not?

Jakob Knorr1, Vittorio Ricci2, Masanori Hatakeyama3, Steffen Backert4.   

Abstract

Since its discovery, Helicobacter pylori has been identified as the causative agent of various gastric diseases. H. pylori produces myriads of disease-associated virulence factors. These bacterial determinants can be distinguished as cell-binding factors, immunoregulatory components, survival factors, toxins, and effector proteins. For most of these factors there is consensus about their classification. However, there is a strong dispute in the literature as to whether one of the best-studied factors, CagA, represents a toxin or not. CagA displays unique functions that are clearly different from conventional toxins, and CagA counteracts the activities of an established H. pylori toxin, VacA. Canonical toxins commonly have specific (and narrow) targets, can act even in the absence of the bacterial cell, and elicit acute damage to host cells. However, there is still no agreement on the classification of CagA. Here we discuss whether CagA acts as a toxin, and propose a classification consensus for CagA.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CagA; Helicobacter pylori; T4SS; VacA; gastric cancer; toxin; type IV secretion

Year:  2019        PMID: 31130493     DOI: 10.1016/j.tim.2019.04.010

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  13 in total

1.  CagA Effector Protein in Helicobacter pylori-Infected Human Gastric Epithelium in Vivo: From Bacterial Core and Adhesion/Injection Clusters to Host Cell Proteasome-Rich Cytosol.

Authors:  Vittorio Necchi; Vittorio Ricci; Patrizia Sommi; Enrico Solcia
Journal:  Toxins (Basel)       Date:  2019-10-25       Impact factor: 4.546

2.  Clarithromycin-Susceptible But Virulent Helicobacter pylori Strains Infecting Iranian Patients' Stomachs.

Authors:  Shadiyeh Khani; Amin Talebi Bezmin Abadi; Ashraf Mohabati Mobarez
Journal:  Infect Drug Resist       Date:  2019-11-01       Impact factor: 4.003

Review 3.  Role of the Gastric Microbiome in Gastric Cancer: From Carcinogenesis to Treatment.

Authors:  Jinpu Yang; Xinxin Zhou; Xiaosun Liu; Zongxin Ling; Feng Ji
Journal:  Front Microbiol       Date:  2021-03-15       Impact factor: 5.640

Review 4.  Helicobacter pylori Pathogenicity Islands and Giardia lamblia Cysteine Proteases in Role of Coinfection and Pathogenesis.

Authors:  Mihret Tilahun; Alemu Gedefie; Chernet Belayhun; Zenawork Sahle; Admasu Abera
Journal:  Infect Drug Resist       Date:  2022-01-06       Impact factor: 4.003

5.  Factors Affect the Eradication Rate of Helicobacter pylori by Modified Quadruple Therapy: A Prospective Cohort Study.

Authors:  Qiao-Li Lan; Hao-Yue Sun; Yi Ye; Ying Wang; Ya Liu; Xue-Jian Weng
Journal:  Infect Drug Resist       Date:  2022-04-29       Impact factor: 4.177

6.  Effects of a Potential Probiotic Strain Lactobacillus gasseri ATCC 33323 on Helicobacter pylori-Induced Inflammatory Response and Gene Expression in Coinfected Gastric Epithelial Cells.

Authors:  Mahdieh Yarmohammadi; Abbas Yadegar; Maryam Tajabadi Ebrahimi; Mohammad Reza Zali
Journal:  Probiotics Antimicrob Proteins       Date:  2020-11-18       Impact factor: 4.609

7.  Cortactin Is Required for Efficient FAK, Src and Abl Tyrosine Kinase Activation and Phosphorylation of Helicobacter pylori CagA.

Authors:  Jakob Knorr; Irshad Sharafutdinov; Florian Fiedler; Delara Soltan Esmaeili; Manfred Rohde; Klemens Rottner; Steffen Backert; Nicole Tegtmeyer
Journal:  Int J Mol Sci       Date:  2021-06-03       Impact factor: 5.923

Review 8.  Global whole family based-Helicobacter pylori eradication strategy to prevent its related diseases and gastric cancer.

Authors:  Song-Ze Ding
Journal:  World J Gastroenterol       Date:  2020-03-14       Impact factor: 5.742

9.  Whole Genome Sequencing Reveals Virulence Potentials of Helicobacter pylori Strain KE21 Isolated from a Kenyan Patient with Gastric Signet Ring Cell Carcinoma.

Authors:  Catherine Mwangi; Stephen Njoroge; Evariste Tshibangu-Kabamba; Zahir Moloo; Allan Rajula; Smita Devani; Takashi Matsumoto; Kimang'a Nyerere; Samuel Kariuki; Gunturu Revathi; Yoshio Yamaoka
Journal:  Toxins (Basel)       Date:  2020-08-29       Impact factor: 4.546

10.  Cortactin Promotes Effective AGS Cell Scattering by Helicobacter pylori CagA, but Not Cellular Vacuolization and Apoptosis Induced by the Vacuolating Cytotoxin VacA.

Authors:  Irshad Sharafutdinov; Jakob Knorr; Delara Soltan Esmaeili; Steffen Backert; Nicole Tegtmeyer
Journal:  Pathogens       Date:  2021-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.